Genetically Confirmed Hyperoxaluria in Iranian Children- A Multicenter Survey
DOI:
https://doi.org/10.61882/ijkd.19.04.8546Keywords:
Primary hyperoxaluria, Kidney replacement therapy, Genetic testing, Combined or sequential liver and kidney transplantationAbstract
Introduction. Primary hyperoxaluria (PH) is a rare autosomal recessive disorder characterized by a heterogeneous presentation that leads to kidney failure and involvement of other organs. The aim of this study was to determine the number of cases with suspected PH in Iran that have had a genetically verified diagnosis.
Methods. A survey distributed among members of Iranian society of pediatric nephrology (IranSPN) to collect overall data on hyperoxaluria (HOX) in their centers, as well as those who performed whole exome sequencing (WES) or sanger sequencing genetic study. Data is presented as frequency and number blocks.
Results. Nineteen out of 130 members filled out the questionnaires. About two-thirds of the responders were suspected to have HOX in the presence of recurrent multiple kidney stones. PH was genetically confirmed in 80 children above 10 years. Alanine-Glyoxylate Aminotransferase (AGXT) was the most frequent reported genetic abnormailtiy. The majority of their patients required kidney replacement therapy. Combined or sequential liver- kidney transplantation was less frequent. Conservative treatment was the only therapy applied to all children prior to end-stage kidney disease.
Conclusion. This simple survey revealed that definitive diagnosis of PH occurs at older age accompanied with higher rate of kidney transplantation.
Downloads
References
1.Mandrile G, Beck B, Acquaviva C, et al. Genetic assessment in primary hyperoxaluria: why it matters. Pediatr Nephrol. 2023;38:625-34.
2.Safaei AA, Maleknejad S. Pediatric urolithiasis an experience of a single center. Iran J Kidney Dis. 2011;5:309-13.
3.Sadeghi S, Fazeli F, Zarifi E. Clinical characteristics and metabolic abnormalities in pediatric urolithiasis in south east Iran. J Ped Nephrol. 2015;3:149-54.
4.Mortazavi F, Mahbubi L. Clinical features and risk factors of pediatric urolithiasis. Iran J Pediatr. 2007;17:129-33.
5.Momtaz HE, Esna Ashari F. Frequency of Metabolic Risk Factors in Children with Urinary Tract Stones Referred to Hamadan Pediatric Nephrology Clinic. Avicenna J Clin Med. 2012;19:11-5.
6.Mojtahedi SY, Abbasi A, Izadi A, Alavije FS, Fahimi D. Metabolic Disorders in Iranian Children with Urolithiasis. Maedica (Bucur). 2019;14:270-73.
7.Mohammadjafari H, Barzin M, Salehifar E, Kord M, Aalaee A, Mohammadjafari R. Etiologic and epidemiologic pattern of urolithiasis in north iran; review of 10-year findings. Inn J Pediatr. 2013;24:69-74.
8.Alemzadeh-Ansari MH, Valavi E, Ahmadzadeh A. Predisposing factors for infantile urinary calculus in south-west of Iran. Iran J Kidney Dis. 2014;8:53-7.
9.Akhavan sepahi M, Sharifian M, Shajari A, Heidary A. Clinical manifestations and etiology of renal and urethra stone in children less than 14 years old referring to Fatemi-e-Sahamieh pediatric hospital in Qom, 2007-2008. J Arak Uni Med Sci. 2009;12:1-7.
10.Ahmadzadeh A, Valavi E, Zangeneh-Kamali M, Ahmadzadeh A. Chronic kidney disease in Southwestern Iranian children. Iran J Pediatr. 2009;19:147-53.
11.Mehrabi S, Rezaie M, Shahbazi Par M, Zoladl M, Jannesar M. Effective factors of Pediatric Urolithiasis in Children under 14 years old that Refer to pediatric and urologic Medical Center of Yasuj at 2010. Armaghan Danesh. 2013;18:315-26.
12.Fallahzadeh MH, Jamali Shirazi M. Etiology of Chroic Renal failue in children living in the south of Iran. Research In Medicine. 2000;24:115-20.
13.Gheissari A, Hemmatzadeh S, Merrikhi A, Fadaei Tehrani S, Madihi Y. Chronic kidney disease in children: A report from a tertiary care center over 11 years. J Nephropathol. 2012;1:177-82.
14.Groothoff JW, Metry E, Deesker L, et al. Clinical practice recommendations for primary hyperoxaluria: an expert consensus statement from ERKNet and OxalEurope. Nat Rev Nephrol. 2023;19:194-211.
15.Pszczolinski R, Acquaviva C, Berrahal I, et al. Primary hyperoxaluria in adults and children: a nationwide cohort highlights a persistent diagnostic delay. Clin Kidney J. 2024;17: sfae099.
16.Peysepar R, Pasha F, Firoozan A, Zabolian A. Early dysfunction of transplanted kidney revealed the cause of recurrent nephrolithiasis: a case report of primary hyperoxaluria. Medical Sciences. 2021;31:465-67.
17.Malakoutian T, Asgari M, Houshmand M, et al. Recurrence of primary hyperoxaluria after kidney transplantation. Iran J Kidney Dis. 2011;5:429-33.
18.Akhavan Sepahi M, Sharif AS, Hooman N, et al. Kidney Calculi in Iranian Children: A Multicentric Report: Kidney Calculi in Iranian Children. J Ped Nephrol. 2023;11(1). Available from: https://journals.sbmu.ac.ir/jpn/article/view/42719
19.Gupta A, Somers MJG, Baum MA. Treatment of primary hyperoxaluria type 1. Clinical Kidney Journal. 2022;15(Supplement_1):i9-i13.
20.Syed YY. Nedosiran: First Approval. Drugs. 2023;83:1729-1733.
21.Naderi G, Tabassomi F, Latif A, Ganji M. The first experience of sequential liver-kidney transplantation for the treatment of primary hyperoxaluria type-1 in Iran as a developing country. Saudi J Kidney Dis Transpl. 2016;27:791-4.
22.Dehghani SM, Lankarani KB, Shahramian I, et al. Liver transplantation outcome in iranian patients with primary hyperoxaluria; risks and perspectives. Nephro-Urol Mon. 2020;12(2) :e100366.
23.Hoppe B, Martin-Higueras C. Improving treatment options for primary hyperoxaluria. Drugs. 2022;82:1077-94.
24.Huang Y, Zhu W, Zhou J, Huang Q, Zeng G. Navigating the Evolving Landscape of Primary Hyperoxaluria: Traditional Management Defied by the Rise of Novel Molecular Drugs. Biomolecules. 2024;14:511.
